1. Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Génitales). (November 2021) Authors: Cancel, Mathilde; Fromont, Gaelle; Blonz, Cyriac; Chevreau, Christine; Rioux-Leclercq, Nathalie; Laguerre, Brigitte; Oudard, Stéphane; Gross-Goupil, Marine; Gravis, Gwenaelle; Goldwasser, François; Rolland, Frédéric; Delva, Rémy; Moise, Laura; Emambux, Sheik; Vassal, Cécile; Zanetta, Sylvie; Pene... Journal: European journal of cancer Issue: Volume 158(2021) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial. Issue 5 (May 2022) Authors: Vano, Yann-Alexandre; Elaidi, Réza; Bennamoun, Mostefa; Chevreau, Christine; Borchiellini, Delphine; Pannier, Diane; Maillet, Denis; Gross-Goupil, Marine; Tournigand, Christophe; Laguerre, Brigitte; Barthélémy, Philippe; Coquan, Elodie; Gravis, Gwenaëlle; Houede, Nadine; Cancel, Mathilde; Huillar... Journal: Lancet oncology Issue: Volume 23:Issue 5(2022) Page Start: 612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of MET status on treatment outcomes in papillary renal cell carcinoma: A pooled analysis of historical data. (July 2022) Authors: Albiges, Laurence; Heng, Daniel Y.C.; Lee, Jae Lyun; Walker, Stephen; Mellemgaard, Anders; Ottesen, Lone; Frigault, Melanie M.; L'Hernault, Anne; Wessen, Jonathan; Choueiri, Toni; Cancel, Mathilde; Signoretti, Sabina Journal: European journal of cancer Issue: Volume 170(2022) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Chemotherapy following immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma. (November 2022) Authors: Meynard, Lucie; Dinart, Derek; Delaunay, Blandine; Fléchon, Aude; Saldana, Carolina; Lefort, Félix; Gravis, Gwenaëlle; Thiery-Vuillemin, Antoine; Cancel, Mathilde; Coquan, Elodie; Ladoire, Sylvain; Maillet, Denis; Rolland, Frédéric; Boughalem, Elouen; Martin, Sophie; Laramas, Mathieu; Crouzet, La... Journal: European journal of cancer Issue: Volume 175(2022) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer. (12th August 2021) Authors: Pobel, Cedric; Auclin, Edouard; Teyssonneau, Diego; Laguerre, Brigitte; Cancel, Mathilde; Boughalem, Elouen; Noel, Johanna; Brachet, Pierre Emmanuel; Maillet, Denis; Barthelemy, Philippe; Helissey, Carole; Thibault, Constance; Oudard, Stéphane Journal: Cancer medicine Issue: Volume 10:Number 18(2021) Page Start: 6304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Preservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial). (August 2021) Authors: Mueller, Volkmar; Wardley, Andrew; Paplomata, Elisavet; Hamilton, Erika; Zelnak, Amelia; Fehrenbacher, Louis; Jakobsen, Erik; Curtit, Elsa; Boyle, Frances; Harder Brix, Eva; Brenner, Andrew; Crouzet, Laurence; Ferrario, Cristiano; Muñoz-Mateu, Montserrat; Arkenau, Hendrik-Tobias; Iqbal, Nayyer; A... Journal: European journal of cancer Issue: Volume 153(2021) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study. (June 2021) Authors: Duffaud, Florence; Italiano, Antoine; Bompas, Emannuelle; Rios, Maria; Penel, Nicolas; Mir, Olivier; Piperno-Neumann, Sophie; Chevreau, Christine; Delcambre, Corinne; Bertucci, François; Boudou-Rouquette, Pascaline; Cancel, Mathilde; Perrin, Christophe; Saada-Bouzid, Esma; Monard, Laure; Schiffle... Journal: European journal of cancer Issue: Volume 150(2021) Page Start: 108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study. Issue 5 (17th October 2022) Authors: Ilie, Mirela Diana; Villa, Chiara; Cuny, Thomas; Cortet, Christine; Assie, Guillaume; Baussart, Bertrand; Cancel, Mathilde; Chanson, Philippe; Decoudier, Bénédicte; Deluche, Elise; Di Stefano, Anna Luisa; Drui, Delphine; Gaillard, Stephan; Goichot, Bernard; Huillard, Olivier; Joncour, Anthony; La... Journal: European journal of endocrinology Issue: Volume 187:Issue 5(2022) Page Start: 685 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Patterns of care and outcome of CIC‐rearranged sarcoma patients: A nationwide study of the French sarcoma group. (20th December 2022) Authors: Brahmi, Mehdi; Gaspar, Nathalie; Gantzer, Justine; Toulmonde, Maud; Boudou‐Rouquette, Pascaline; Bompas, emmanuelle; Firmin, Nelly; Valentin, Thibaud; Cancel, Mathilde; Duffaud, Florence; Bertucci, Francois; Perrin, Christophe; Dufresne, Armelle; Marec‐Bérard, Perrine; Jean‐Denis, Myriam; Ray‐Coq... Journal: Cancer medicine Issue: Volume 12:Number 7(2023) Page Start: 7801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗